Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $14.81 billion. The enterprise value is $10.99 billion.
| Market Cap | 14.81B |
| Enterprise Value | 10.99B |
Important Dates
The next confirmed earnings date is Tuesday, July 30, 2024, before market open.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 224.86 million shares outstanding. The number of shares has increased by 0.72% in one year.
| Shares Outstanding | 224.86M |
| Shares Change (YoY) | +0.72% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 1.72% |
| Owned by Institutions (%) | 97.12% |
| Float | 192.11M |
Valuation Ratios
The trailing PE ratio is 19.96 and the forward PE ratio is 13.97. Incyte's PEG ratio is 0.69.
| PE Ratio | 19.96 |
| Forward PE | 13.97 |
| PS Ratio | 3.93 |
| Forward PS | 3.46 |
| PB Ratio | 2.75 |
| P/FCF Ratio | 18.73 |
| PEG Ratio | 0.69 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.93, with an EV/FCF ratio of 13.90.
| EV / Earnings | 14.74 |
| EV / Sales | 2.92 |
| EV / EBITDA | 9.93 |
| EV / EBIT | 10.77 |
| EV / FCF | 13.90 |
Financial Position
The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.47 |
| Quick Ratio | 3.29 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.04 |
| Interest Coverage | 406.46 |
Financial Efficiency
Return on equity (ROE) is 14.70% and return on invested capital (ROIC) is 9.27%.
| Return on Equity (ROE) | 14.70% |
| Return on Assets (ROA) | 11.20% |
| Return on Capital (ROIC) | 9.27% |
| Revenue Per Employee | $1.49M |
| Profits Per Employee | $295,342 |
| Employee Count | 2,524 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.07 |
Taxes
In the past 12 months, Incyte has paid $273.07 million in taxes.
| Income Tax | 273.07M |
| Effective Tax Rate | 26.81% |
Stock Price Statistics
The stock price has increased by +4.72% in the last 52 weeks. The beta is 0.74, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +4.72% |
| 50-Day Moving Average | 59.71 |
| 200-Day Moving Average | 58.00 |
| Relative Strength Index (RSI) | 69.92 |
| Average Volume (20 Days) | 2,915,718 |
Short Selling Information
The latest short interest is 16.93 million, so 7.53% of the outstanding shares have been sold short.
| Short Interest | 16.93M |
| Short Previous Month | 18.72M |
| Short % of Shares Out | 7.53% |
| Short % of Float | 8.81% |
| Short Ratio (days to cover) | 2.93 |
Income Statement
In the last 12 months, Incyte had revenue of $3.77 billion and earned $745.44 million in profits. Earnings per share was $3.30.
| Revenue | 3.77B |
| Gross Profit | 3.51B |
| Operating Income | 687.65M |
| Pretax Income | 1.02B |
| Net Income | 745.44M |
| EBITDA | 1.11B |
| EBIT | 1.02B |
| Earnings Per Share (EPS) | $3.30 |
Balance Sheet
The company has $3.85 billion in cash and $32.61 million in debt, giving a net cash position of $3.82 billion or $16.99 per share.
| Cash & Cash Equivalents | 3.85B |
| Total Debt | 32.61M |
| Net Cash | 3.82B |
| Net Cash Per Share | $16.99 |
| Equity (Book Value) | 5.39B |
| Book Value Per Share | 23.99 |
| Working Capital | 3.45B |
Cash Flow
In the last 12 months, operating cash flow was $820.90 million and capital expenditures -$30.13 million, giving a free cash flow of $790.77 million.
| Operating Cash Flow | 820.90M |
| Capital Expenditures | -30.13M |
| Free Cash Flow | 790.77M |
| FCF Per Share | $3.52 |
Margins
Gross margin is 93.12%, with operating and profit margins of 18.25% and 19.78%.
| Gross Margin | 93.12% |
| Operating Margin | 18.25% |
| Pretax Margin | 27.03% |
| Profit Margin | 19.78% |
| EBITDA Margin | 29.36% |
| EBIT Margin | 27.10% |
| FCF Margin | 20.99% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.72% |
| Shareholder Yield | -0.72% |
| Earnings Yield | 5.03% |
| FCF Yield | 5.34% |
Analyst Forecast
The average price target for Incyte is $71.14, which is 8.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $71.14 |
| Price Target Difference | 8.00% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 9.13% |
| EPS Growth Forecast (5Y) | 24.77% |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 6.75 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.75 |
| Piotroski F-Score | 5 |